Richard W. Joseph, MD

Articles by Richard W. Joseph, MD

Dr. Joseph on Factors Influencing Frontline Therapy Selection in mRCC

August 5th 2019

Richard W. Joseph, MD, internist and oncologist, Mayo Clinic, discusses considerations for frontline therapy selection in metastatic renal cell carcinoma (mRCC).

Dr. Joseph on Selecting Frontline Therapy in mRCC

ByRichard W. Joseph, MD

August 3rd 2019

Richard W. Joseph, MD, internist and oncologist, Mayo Clinic, discusses the process of selecting frontline therapy in metastatic renal cell carcinoma (mRCC).

Latest Updated Articles

Dr. Joseph on Factors Influencing Frontline Therapy Selection in mRCC
Published: August 5th 2019 | Updated:
Dr. Joseph on Selecting Frontline Therapy in mRCC
Published: August 3rd 2019 | Updated: